isis 353512
Nucleic acidexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00734240)
Timeline
Indications
Mechanism of action
- C-reactive proteinSupplementation
CRP supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- isis 353512
- isis crp
- isis crp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01710852 | Phase 2 | Oct 1, 2012 | Ionis Pharmaceuticals, Inc. |
| NCT01414101 | Phase 2 | Aug 1, 2011 | Ionis Pharmaceuticals, Inc. |
| NCT00734240 | Phase 1 | Jul 1, 2008 | Ionis Pharmaceuticals, Inc., SFBC Anapharm |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2008 |
| SFBC Anapharm | For profit | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1